Another study revealed that the leucine-rich repeat-containing protein 1 (LRRC1) is upregulated in the bone marrow tissues of AML patients and AML cells, and lower overall survival was observed in patients with higher LRRC1 expression. This evidence concerns the gene LRRC1 and acute myeloid leukemia.